Disease specific urinary biomarkers in the central nervous system.

Autor: Duggins-Warf M; Vascular Biology Program, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA.; Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA., Ghalali A; Vascular Biology Program, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA.; Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA., Sesen J; Vascular Biology Program, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA.; Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA., Martinez T; Vascular Biology Program, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA.; Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA., Fehnel KP; Vascular Biology Program, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA.; Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA., Pineda S; Vascular Biology Program, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA.; Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA., Zurakowski D; Department of Surgery, Boston Children's Hospital, Boston, MA, USA., Smith ER; Vascular Biology Program, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA. edward.smith@childrens.harvard.edu.; Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA. edward.smith@childrens.harvard.edu.
Jazyk: angličtina
Zdroj: Scientific reports [Sci Rep] 2023 Nov 07; Vol. 13 (1), pp. 19244. Date of Electronic Publication: 2023 Nov 07.
DOI: 10.1038/s41598-023-46763-z
Abstrakt: Urinary biomarkers can diagnose and monitor pathophysiologic conditions in the central nervous system (CNS). However, focus is often on single diseases, with limited data on discriminatory capability of this approach in a general setting. Here, we demonstrate that different classes of CNS disease exhibit distinct biomarker patterns, evidence of disease-specific "fingerprinting." Urine from 218 patients with pathology-confirmed tumors or cerebrovascular disease, controls (n = 33) were collected. ELISA and/or bead-based multiplexing quantified levels of 21 putative urinary biomarkers. Analysis identified biomarkers capable of distinguishing each disease from controls and other diseases. Mann-Whitney U tests identified biomarkers with differential expression between disease types and controls (P ≤ 0.001). Subsequent receiver-operating characteristic (ROC) analyses revealed distinguishing biomarkers with high sensitivity and specificity. Areas under the curve (AUCs) ranged 0.8563-1.000 (P values ≤ 0.0003), sensitivities ranged 80.00-100.00%, and specificities ranged 80.95-100.00%. These data demonstrate proof-of-principle evidence that disease-specific urinary biomarker signatures exist. In contrast to non-specific responses to ischemia or injury, these results suggest that urinary biomarkers accurately reflect unique biological processes distinct to different diseases. This work can be used to generate disease-specific panels for enhancing diagnosis, assisting less-invasive follow-up and herald utility by revealing putative disease-specific therapeutic targets.
(© 2023. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje